ENDO 2017

Interesting T2DM: Pharmacotherapy & Obesity Outcomes

Apr 12, 2017

Our April list includes CV events with DPP-4 or SGLT2 inhibitors vs. insulin, and impact of obesity on nonalcoholic fatty liver disease and thyroid function.

Obesity Management: ENDO 2017 Highlights

Apr 07, 2017

Could corticosteroid use put your patients at a greater risk of metabolic syndrome?

Endo 2017: Men’s Health

Apr 04, 2017

Men’s health studies presented at ENDO 2017 included a possible prostate cancer treatment and the potential of hormone therapy to prevent frailty.

Endo 2017: Improve Diabetes, Obesity Care

Apr 04, 2017

Three studies from ENDO 2017 focused on improving patient care through brain stimulation, an artificial pancreas system, and videoconferencing.

Can We Suppress Sugar Cravings?

Apr 03, 2017

Researchers sought to discover the specific physiological pathways of fibroblast growth factor 21.

Clinical Dilemmas in Diabetes

Apr 03, 2017

Research presented at ENDO 2017 explored options to reduce complications in patients with diabetes and microalbuminuria and patients with cystic fibrosis.

ENDO 2017: Sleep Studies

Apr 03, 2017

Studies presented at ENDO 2017 examined the impact of sleep disorders on gestational diabetes, bone formation, and adolescents with and without diabetes.

Role of the Striatum in Obesity

Apr 02, 2017

Researchers investigated possible differences in the function of the striatum both before and after the development of obesity.

ENDO 2017: Top Sessions

Mar 31, 2017

You won’t want to miss these top sessions and new features at this year’s Endocrinology Society’s annual meeting, April 1-4, in Orlando, FL.